![As U.S. courts, politicians take aim at preventive care, cervical cancer screening declines, HPV vaccine uptake stays uneven](https://cdn.cancerletter.com/media/2023/07/21142848/49-29-4x3-1.jpg)
![As U.S. courts, politicians take aim at preventive care, cervical cancer screening declines, HPV vaccine uptake stays uneven](https://cdn.cancerletter.com/media/2023/07/21142848/49-29-4x3-1.jpg)
Cover Story
In an era of intensifying judicial repudiation of evidence-based guidelines and deepening public mistrust toward science, America’s screening rate for cervical cancer has been declining.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Clinical Roundup
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
Drugs & Targets
Trending Stories
- Trump et al. are wrong: Biden Cancer Initiative is not to be confused with the Beau Biden Cancer Moonshot
- House GOP leaders propose “streamlining” NIH into 15 institutes and centers
Plan calls for slashing ARPA-H, adding oversight to infectious disease research - “Father of tamoxifen” V. Craig Jordan dies at 76
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Robert L. Ferris named executive director of UNC Lineberger—with an additional job as chief of oncology services